Cart
sales@molnova.com
LTI-291
CAS No. 1919820-28-2
LTI-291( LTI-291 | LTI 291 | LTI291 )
Catalog No. M18176 CAS No. 1919820-28-2
LTI-291 is a glucocerebrosidase (Gcase) activator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 53 | In Stock |
|
| 5MG | 87 | In Stock |
|
| 10MG | 147 | In Stock |
|
| 25MG | 295 | In Stock |
|
| 50MG | 475 | In Stock |
|
| 100MG | 692 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLTI-291
-
NoteResearch use only, not for human use.
-
Brief DescriptionLTI-291 is a glucocerebrosidase (Gcase) activator.
-
DescriptionLTI-291 is a glucocerebrosidase (Gcase) activator for treatment of Parkinson's disease (PD).
-
In Vitro——
-
In Vivo——
-
SynonymsLTI-291 | LTI 291 | LTI291
-
PathwayOthers
-
TargetOther Targets
-
Recptorβ-glucosidase
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number1919820-28-2
-
Formula Weight358.49
-
Molecular FormulaC20H30N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 139.48 mM;
-
SMILESO=C(C1=C2N=C(C)C=C(C)N2N=C1)N[C@H]3CC[C@H](OCCCCC)CC3
-
Chemical Name5,7-Dimethyl-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (trans-4-pentyloxy-cyclohexyl)-amide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Renato T. Skerlj, et al. Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds. WO 2017192841 A1.
molnova catalog
related products
-
Proteinase
Proteinases are enzymes that catalyse the breakdown of proteins. Proteinases are involved in many biological functions, including the digestion of ingested proteins, the breakdown of old proteins, and cell signalling.
-
Pentadecanoic acid
Pentadecylic acid is a saturated fatty acid with a 15-carbon backbone.
-
ALX 40-4C Trifluoroa...
Alx40-4C trifluoroacetate is a chemokine receptor (CXCR4) inhibitor, which inhibits the binding of sdf-1 to CXCR4.Alx40-4ctrifluoroacetate was also an APJ receptor antagonist with an IC50 value of 2.9 M.
